RxDoctor Payments Data

Joel Bentz, MD

Anatomic Pathology & Clinical Pathology · Las Vegas, NVNPI 1588754113

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Bayer accounts for 67.6% of it on its own, with 1 other manufacturer making up the rest.

$185in general payments, 2019–2025

Across 2 payments — averaging $92.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$125
  • Abbott$60
$681,701in research payments, 2019–2025

Across 46 payments — averaging $14,820 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ventana Medical Systems, Inc.$682K

What the payments were for

  • Food & beverage$185100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer1$125
Abbott1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$185 in reported general payments places this provider in the 60th percentile of 52 anatomic pathology & clinical pathology providers in Nevada.

See all anatomic pathology & clinical pathology providers in Nevada

Medicare billing

Part B allowed, 2024
$20,180
Medicare patients
176
Services billed
568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →